WhiteOak Capital Pharma and Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.18%)Nav, as on 07-11-2025

  • Previous Nav

  • Net Change on 07-11-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 -0.63 20.52 17.79 1.82 8,113.59
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 2.37 26.17 20.20 1.87 6,226.82
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 1.03 23.72 19.49 1.93 3,933.26
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 -5.92 20.62 17.23 1.93 3,074.18
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 -0.95 20.07 17.41 1.93 2,761.64

Fund Holdings as on 31-October-2025

  • Sun Pharmaceutical Industries Limited

  • Divi's Laboratories Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Fortis Healthcare Limited

  • Clearing Corporation of India Ltd

  • Laurus Labs Limited

  • Cipla Limited

  • Neuland Laboratories Limited

  • Lupin Limited

  • Sai Life Sciences Limited

  • Krishna Institute Of Medical Sciences Limited

  • Max Healthcare Institute Limited

  • Thyrocare Technologies Limited

  • Abbott India Limited

  • Ajanta Pharma Limited

  • Vijaya Diagnostic Centre Limited

  • Jupiter Life Line Hospitals Limited

  • Mankind Pharma Limited

  • Gland Pharma Limited

  • Kovai Medical Center and Hospital Limited

  • Alembic Pharmaceuticals Limited

  • Pfizer Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Apollo Hospitals Enterprise Limited

  • AstraZeneca Pharma India Limited

  • Glenmark Pharmaceuticals Limited

  • Eris Lifesciences Limited

  • Emcure Pharmaceuticals Limited

  • Shaily Engineering Plastics Limited

  • Alkem Laboratories Limited

  • Acutaas Chemicals Limited

  • Strides Pharma Science Limited

  • Poly Medicure Limited

  • 364 Days Tbill (MD 18/12/2025)

  • 182 Days Tbill (MD 25/12/2025)

  • Healthcare Global Enterprises Limited

  • Navin Fluorine International Limited

  • Anthem Biosciences Limited

  • Dr.Agarwals Eye Hospital Limited

  • Supriya Lifescience Limited

  • Shilpa Medicare Limited

  • Zota Health Care Limited

  • Piramal Pharma Limited

  • Aster DM Healthcare Limited

  • 91 Days Tbill (MD 15/01/2026)

  • Orchid Pharma Limited

  • 91 Days Tbill (MD 04/12/2025)

  • 91 Days Tbill (MD 20/11/2025)

  • 91 Days Tbill (MD 28/11/2025)

  • 364 Days Tbill (MD 11/12/2025)

  • 91 Days Tbill (MD 08/01/2026)

  • Net Receivables / (Payables)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Plastic Products

  • Medical Equipment/Supplies/Accessories

  • Chemicals

  • Fintech

View More

Fund Manager

  • Cash

  • Equity

  • Sovereign

View More

About WhiteOak Capital Pharma and Healthcare Fund

Scheme Analysis

WhiteOak Capital Pharma and Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to WhiteOak Capital Mutual Fund. It was launched on 06-Feb-2024 and currently has an AUM of ₹480.08 crore. WhiteOak Capital Pharma and Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of WhiteOak Capital Pharma and Healthcare Fund ended down ₹-0.03(-0.18%)yesterday to ₹14.125.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The WhiteOak Capital Pharma and Healthcare Fund is managed by Piyush Baranwal and Ramesh Mantri.

Fund House Contact

Unit No. B4, 6th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025

022-6918 7607
022 69187643